|
1
|
Molyneux EM, Rochford R, Griffin B, Newton
R, Jackson G, Menon G, Harrison CJ, Israels T and Bailey S:
Burkitt's lymphoma. Lancet. 379:1234–1244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sacks D, Baxter B, Campbell BCV, Carpenter
JS, Cognard C, Dippel D, Eesa M, Fischer U, Hausegger K, Hirsch JA,
et al: Multisociety Consensus Quality Improvement Revised Consensus
Statement for Endovascular Therapy of Acute Ischemic Stroke. Int J
Stroke. 13:612–632. 2018.PubMed/NCBI
|
|
3
|
Senbanjo IO: Tumor lysis and acute renal
failure in Burkitt's lymphoma: A review on pathophysiology and
management. Indian J Nephrol. 19:83–86. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bain BJ: Pseudoplatelets and apoptosis in
Burkitt lymphoma. Am J Hematol. 94:1168–1169. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uchida S and Dimmeler S: Long noncoding
RNAs in cardiovascular diseases. Circ Res. 116:737–750. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qureshi IA, Mattick JS and Mehler MF: Long
non-coding RNAs in nervous system function and disease. Brain Res.
1338:20–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Losko M, Kotlinowski J and Jura J: Long
Noncoding RNAs in Metabolic Syndrome Related Disorders. Mediators
Inflamm. 2016:53652092016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dykes IM and Emanueli C: Transcriptional
and Post-transcriptional Gene Regulation by Long Non-coding RNA.
Genomics Proteomics Bioinformatics. 15:177–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi S, Lu Y, Qin Y, Li W, Cheng H, Xu Y,
Xu J, Long J, Liu L, Liu C, et al: miR-1247 is correlated with
prognosis of pancreatic cancer and inhibits cell proliferation by
targeting neuropilins. Curr Mol Med. 14:316–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pasmant E, Sabbagh A, Vidaud M and Bièche
I: ANRIL, a long, noncoding RNA, is an unexpected major hotspot in
GWAS. FASEB J. 25:444–448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH, et al: Long noncoding RNA ANRIL
promotes non-small cell lung cancer cell proliferation and inhibits
apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther.
14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Feng L, Liu P and Duan W: ANRIL
promotes chemoresistance via disturbing expression of ABCC1 by
regulating the expression of Let-7a in colorectal cancer. Biosci
Rep. 38:382018. View Article : Google Scholar
|
|
15
|
Zhu H, Li X, Song Y, Zhang P, Xiao Y and
Xing Y: Long non-coding RNA ANRIL is up-regulated in bladder cancer
and regulates bladder cancer cell proliferation and apoptosis
through the intrinsic pathway. Biochem Biophys Res Commun.
467:223–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang MD, Chen WM, Qi FZ, Xia R, Sun M, Xu
TP, Yin L, Zhang EB, De W and Shu YQ: Long non-coding RNA ANRIL is
upregulated in hepatocellular carcinoma and regulates cell
apoptosis by epigenetic silencing of KLF2. J Hematol Oncol.
8:502015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
Noncoding RNA ANRIL Promotes Cervical Cancer Development by Acting
as a Sponge of miR-186. Oncol Res. 26:345–352. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang EB, Kong R, Yin DD, You LH, Sun M,
Han L, Xu TP, Xia R, Yang JS, De W, et al: Long noncoding RNA ANRIL
indicates a poor prognosis of gastric cancer and promotes tumor
growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget.
5:2276–2292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chai L, Yuan Y, Chen C, Zhou J and Wu Y:
The role of long non-coding RNA ANRIL in the carcinogenesis of oral
cancer by targeting miR-125a. Biomed Pharmacother. 103:38–45. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Derynck R and Budi EH: Specificity,
versatility, and control of TGF-β family signaling. Sci Signal.
12:122019. View Article : Google Scholar
|
|
21
|
Kawabata KC, Ehata S, Komuro A, Takeuchi K
and Miyazono K: TGF-β-induced apoptosis of B-cell lymphoma Ramos
cells through reduction of MS4A1/CD20. Oncogene. 32:2096–2106.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen D, Zhang Z, Mao C, Zhou Y, Yu L, Yin
Y, Wu S, Mou X and Zhu Y: ANRIL inhibits p15(INK4b) through the
TGFβ1 signaling pathway in human esophageal squamous cell
carcinoma. Cell Immunol. 289:91–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo J, Zhang K, Ji Y, Jiang X and Zuo S:
Effects of ethyl pyruvate on myocardial apoptosis and expression of
Bcl-2 and Bax proteins after ischemia-reperfusion in rats. Journal
of Huazhong University of Science and Technology. J Huazhong Univ
Sci Technol. 28:281–283. 2008. View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schmitz SU, Grote P and Herrmann BG:
Mechanisms of long noncoding RNA function in development and
disease. Cell Mol Life Sci. 73:2491–2509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu X, Tudoran OM, Calin GA and Ivan M: The
Many Faces of Long Noncoding RNAs in Cancer. Antioxid Redox Signal.
29:922–935. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mehta-Mujoo PM, Cunliffe HE, Hung NA and
Slatter TL: Long Non-coding RNA ANRILin the Nucleus Associates With
Periostin Expression in Breast Cancer. Front Oncol. 9:8852019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li R, He JL, Chen XM, Long CL, Yang DH,
Ding YB, Qi HB and Liu XQ: miR-200a is involved in proliferation
and apoptosis in the human endometrial adenocarcinoma cell line
HEC-1B by targeting the tumor suppressor PTEN. Mol Biol Rep.
41:1977–1984. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hao YR, Zhang DJ, Fu ZM, Guo YY and Guan
GF: Long non-coding RNA ANRIL promotes proliferation,
clonogenicity, invasion and migration of laryngeal squamous cell
carcinoma by regulating miR-181a/Snai2 axis. Regen Ther.
11:282–289. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang D, Bi C, Zhao Q, Ding X, Bian C,
Wang H, Wang T and Liu H: Knockdown long non-coding RNA ANRIL
inhibits proliferation, migration and invasion of HepG2 cells by
down-regulation of miR-191. BMC Cancer. 18:9192018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mei JM and Niu CS: Effects of CDNF on
6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax
and caspase-3 activation. Neurol Sci. 35:1275–1280. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang H, Zhao PJ, Su D, Feng J and Ma SL:
Paris saponin I induces apoptosis via increasing the Bax/Bcl-2
ratio and caspase-3 expression in gefitinib-resistant non-small
cell lung cancer in vitro and in vivo. Mol Med Rep.
9:2265–2272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Samarghandian S, Nezhad MA and Mohammadi
G: Role of caspases, Bax and Bcl-2 in chrysin-induced apoptosis in
the A549 human lung adenocarcinoma epithelial cells. Anticancer
Agents Med Chem. 14:901–909. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Galluzzi L, Kepp O and Kroemer G:
Caspase-3 and prostaglandins signal for tumor regrowth in cancer
therapy. Oncogene. 31:2805–2808. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim B, Srivastava SK and Kim SH: Caspase-9
as a therapeutic target for treating cancer. Expert Opin Ther
Targets. 19:113–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takano S, Shiomoto S, Inoue KY, Ino K,
Shiku H and Matsue T: Electrochemical approach for the development
of a simple method for detecting cell apoptosis based on caspase-3
activity. Anal Chem. 86:4723–4728. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hastak K, Gupta S, Ahmad N, Agarwal MK,
Agarwal ML and Mukhtar H: Role of p53 and NF-kappaB in
epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Oncogene. 22:4851–4859. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Massagué J: TGFbeta in Cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huynh LK, Hipolito CJ and Ten Dijke P: A
Perspective on the Development of TGF-β Inhibitors for Cancer
Treatment. Biomolecules. 9:92019. View Article : Google Scholar
|
|
41
|
Abou-Shady M, Baer HU, Friess H, Berberat
P, Zimmermann A, Graber H, Gold LI, Korc M and Büchler MW:
Transforming growth factor betas and their signaling receptors in
human hepatocellular carcinoma. Am J Surg. 177:209–215. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gholamin M, Moaven O, Memar B, Farshchian
M, Naseh H, Malekzadeh R, Sotoudeh M, Rajabi-Mashhadi MT, Forghani
MN, Farrokhi F, et al: Overexpression and interactions of
interleukin-10, transforming growth factor beta, and vascular
endothelial growth factor in esophageal squamous cell carcinoma.
World J Surg. 33:1439–1445. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao JJ, Hao S, Wang LL, Hu CY, Zhang S,
Guo LJ, Zhang G, Gao B, Jiang Y, Tian WG, et al: Long non-coding
RNA ANRIL promotes the invasion and metastasis of thyroid cancer
cells through TGF-β/Smad signaling pathway. Oncotarget.
7:57903–57918. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vander Ark A, Cao J and Li X: TGF-β
receptors: In and beyond TGF-β signaling. Cell Signal. 52:112–120.
2018. View Article : Google Scholar
|
|
45
|
Derynck R, Akhurst RJ and Balmain A:
TGF-beta signaling in tumor suppression and cancer progression. Nat
Genet. 29:117–129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Stelling A, Hashwah H, Bertram K, Manz MG,
Tzankov A and Müller A: The tumor suppressive TGF-β/SMAD1/S1PR2
signaling axis is recurrently inactivated in diffuse large B-cell
lymphoma. Blood. 131:2235–2246. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bakkebø M, Huse K, Hilden VI, Smeland EB
and Oksvold MP: TGF-β-induced growth inhibition in B-cell lymphoma
correlates with Smad1/5 signalling and constitutively active p38
MAPK. BMC Immunol. 11:572010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Spender LC, O'Brien DI, Simpson D, Dutt D,
Gregory CD, Allday MJ, Clark LJ and Inman GJ: TGF-beta induces
apoptosis in human B cells by transcriptional regulation of BIK and
BCL-XL. Cell Death Differ. 16:593–602. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang B, Wang D, Ji TF, Shi L and Yu JL:
Overexpression of lncRNA ANRIL up-regulates VEGF expression and
promotes angiogenesis of diabetes mellitus combined with cerebral
infarction by activating NF-κB signaling pathway in a rat model.
Oncotarget. 8:17347–17359. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen S, Zhang JQ, Chen JZ, Chen HX, Qiu
FN, Yan ML, Chen YL, Peng CH, Tian YF and Wang YD: The over
expression of long non-coding RNA ANRIL promotes
epithelial-mesenchymal transition by activating the ATM-E2F1
signaling pathway in pancreatic cancer: An in vivo and in vitro
study. Int J Biol Macromol. 102:718–728. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sun LY, Li XJ, Sun YM, Huang W, Fang K,
Han C, Chen ZH, Luo XQ, Chen YQ and Wang WT: lncRNA ANRIL regulates
AML development through modulating the glucose metabolism pathway
of AdipoR1/AMPK/SIRT1. Mol Cancer. 17:1272018. View Article : Google Scholar : PubMed/NCBI
|
